Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen

Fatal interstitial lung disease (ILD) is one of the rare side effects of Panitumumab. Both fatal and non-fatal ILD have been reported mainly in the Japanese population. We report a case of a nonsmoking Caucasian man with the diagnosis of metastatic rectal cancer (K-RAS wild-type) who developed fatal...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-asadi, Osamah, Almusarhed, Manar, Rizvi, Syed Azhar J, Saka, Wasiru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027982/
https://www.ncbi.nlm.nih.gov/pubmed/30034518
http://dx.doi.org/10.3332/ecancer.2018.841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027982/
https://www.ncbi.nlm.nih.gov/pubmed/30034518
http://dx.doi.org/10.3332/ecancer.2018.841

Ejemplares similares